Adil Yerezhepov

Dr. Adil Yerezhepov


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
AGAidana Gabdulkayum
Aidana Gabdulkayum
SASaya Amangeldikyzy
Saya Amangeldikyzy
AYAdil Yerezhepov
Adil Yerezhepov
SKSayipzhamal Khassanova
Sayipzhamal Khassanova
KAKenes Akilzhanov
Kenes Akilzhanov
DYDauren Yerezhepov
Dauren Yerezhepov
Background/Objectives: We aimed to investigate the association between VDR gene variants and vitamin D levels in elite male power athletes of Kazakhstan. Methods: We recruited 92 elite male power athletes of Kazakhstan. Concentrations of serum 25(OH)D were measured with the Access 25(OH) Vitamin D Total Assay on the Unicel Dxl 800 Access Immunoassay System. Gene polymorphisms were determined by a real-time polymerase chain reaction (RT-PCR) allelic discrimination assay using TaqMan™ probes. Results: Vitamin D insufficiency was registered in 63% of athletes. Age (χ2 = 6.83, p < 0.01), BMI (χ2 = 6.83, p < 0.01), and sport experience (χ2 = 4.44, p < 0.04) showed a statistically significant association with vitamin D insufficiency and deficiency (age, χ2 = 7.93, p < 0.01; BMI, χ2 = 5.11, p < 0.03; sport experience, χ2 = 6.19, p = 0.01). The A/A genotype of the VDR FokI polymorphism (rs2228570) showed a strong correlation with vitamin D insufficiency (G/G-G/A vs. A/A, OR = 9.25, 95% CI = 2.01–42.51, p < 0.01) but not deficiency. Conclusions: Our study reveals a significant prevalence of vitamin D insufficiency and deficiency among elite male power athletes of Kazakhstan. Age, BMI, and sport experience are essential factors in developing personalized strategies to address vitamin D insufficiency. The A/A genotype of the VDR FokI polymorphism can be used as a potential biomarker for vitamin D inadequacy in elite male power athletes of Kazakhstan.

1 January 2024 in Experimental Biology
Verified
Journal Article
Open access
PDF file
ЕКЕ.а. Киршибаев
Е.а. Киршибаев
ГТГ. Төлеева
Г. Төлеева
AYAdil Yerezhepov
Adil Yerezhepov
AOAdilkhan Orazbayev
Adilkhan Orazbayev
STSvetlana Turasheva
Svetlana Turasheva
ЭСЭ.у. Сагиндыкова
Э.у. Сагиндыкова
In recent years, due to the increasing anthropogenic load on the environment, research has inten-sified to identify local plants-phytoremediators of heavy metals. In the article have been considered the phytoremediation capacity of lawn grasses and sunflowers to adsorb heavy metals such as zinc, cadmium, lead, and copper from the soil on the territory of the Ulbi metallurgical complex in the city of Ust-Kamenogorsk. Currently, the search for plants that accumulate heavy metals is actively underway. Based on a review of literature data, among species with the ability to phytoremediation, sunflower plants (Heliantus annuus L.) and a grass mixture of different species belong to Poaceaefamily (Agropyron repens (L.) P. Beauv. (wheatgrass),Bromus inermis Leyss. (brome), Agrostis alba L.(bentgrass) and Dactylis glomerata L. (urchin) were used as research objects. The choice of objects of study is also justified by the fact that sunflower has a large vegetative mass and, accordingly, its ab-sorption and accumulation capacity for heavy metals is higher, and lawn grasses grow everywhere and their accumulation capacity, as the results of experiments have shown, is also large. The correlation between the degree of soil contamination with heavy metals and the intensity of their entry into plants was shown. Thus, the content of zinc in the soil can be reduced by 22.5%, cadmium by 31%, lead by 40.7%, copper by 29.4% due to adsorb capacity of phytoremediators. It has been established that the intensity of absorption of heavy metals is higher in corn plants compared with plants from the grass mixture. The experimental results may be useful for the development of technology for phytoremedia-tion of soils contaminated with heavy metals.

20 March 2026 in Experimental Biology
Verified
Journal Article
Open access
AGAidana Gabdulkayum
Aidana Gabdulkayum
ZMZ. Mirmanova
Z. Mirmanova
ТKТ. Kadenova
Т. Kadenova
MBMirgul Bayanova
Mirgul Bayanova
LNL. Nazarova
L. Nazarova
ДЕД. Ережепов
Д. Ережепов
Mitochondria, commonly known as the cell’s power generator, carry out their primary function through oxidative phosphorylation (OXPHOS), a process that produces ATP, the main energy source of the cell and the only cell organelles with their own mitochondrial DNA. Any genetic alterations in DNA sequences that encode mitochondrial structural or functional proteins may cause mitochondrial disorders. Multiple mitochondrial dysfunction syndrome type 3 (MMDS3) is a rare autosomal recessive mitochondrial disorder caused by homozygous or biallelic pathogenic variants in the IBA57 gene. In the current study, we present a case report on prenatal genetic testing for multiple mitochondrial dysfunction syndrome (MMDS) type 3 caused by the IBA57 gene to highlight the importance of prenatal diagnostics for disease prognosis and treatment, appropriate genetic counselling, and informed reproductive decision-making. We recruited a 27-year-old G2P1001 at 22 weeks’ gestation with MMDS3 in family history, confirmed by whole exome sequencing (WES) and also verified by Sanger sequencing in the IBA57 gene c.286T>C (NM_001010867.4, p.Tyr96His) and c.667C>G (NM_001010867.4, p.Arg223Gly) in the proband and parents. The ccfDNA genetic test revealed the absence of the heterozygous IBA57 gene variant at position c.286T>C (NM_001010867.4, p.Tyr96His), but the heterozygous IBA57 gene variant at position c.667C>G (NM_001010867.4, p.Arg223Gly) was detected. The child is a heterozygous carrier of the genetic variant of the IBA57 gene at position c.667C>G (NM_001010867.4, p.Arg223Gly). No specific treatment is required; observation by a pediatrician and medical and genetic counseling of the couple when planning the next pregnancy are recommended. The IBA57 gene-related MMDS3 can have a wide range of outcomes and consequences and may progress rapidly. Early awareness is crucial to prompt and proper administration. Our study reveals the importance of early prenatal genetic testing for IBA57-related MMDS3 for early diagnostics and consent decision-making.

30 April 2026 in Наука и здравоохранение
Verified
Journal Article
Open access
PDF file
AGAidana Gabdulkayum
Aidana Gabdulkayum
ZMZhanel Mirmanova
Zhanel Mirmanova
TKTomiris Kadenova
Tomiris Kadenova
MBMirgul Bayanova
Mirgul Bayanova
LNLyazzat Nazarova
Lyazzat Nazarova
DYDauren Yerezhepov
Dauren Yerezhepov
Introduction. One of the global causes of mortality and disability is neurological disorders, which have a mostly genetic aetiology. Spinal muscular atrophy (SMA) is a common autosomal recessive neuromuscular disorder caused by pathogenic mutations in the SMN1gene, leading to progressive degeneration of motor neurons. Advances in molecular genetics and the emergence of disease-modifying therapies have increased the importance of early diagnosis, including prenatal testing and carrier screening. Aim. To investigate the role of prenatal genetic testing in families at risk of SMA and to evaluate its importance for early diagnosis, assessment of disease severity, and informed reproductive decision-making. Materials and methods. Pregnant women at risk of SMA were recruited. Biomaterial (maternal blood and fetal samples via chorionic villus sampling or placentocentesis) was collected. DNA was extracted and analyzed by MLPA to assess copy number variation in the SMN1, SMN2, and NAIP genes. Variants identified by next-generation sequencing were confirmed by Sanger sequencing. Clinical and family histories were recorded for all participants. Discussion. Two clinical cases demonstrated the value of prenatal genetic testing. In one case, parents were carriers. Nevertheless, the fetus was unaffected. The pregnancy was recommended to continue. In the second case, a homozygous deletion of SMN1 was detected, leading to pregnancy termination after counseling. These findings highlight the critical role of prenatal diagnosis in identifying affected fetuses, guiding clinical decisions, and preventing recurrence. The variability of SMA severity, influenced by SMN2 copy number, further emphasizes the need for comprehensive molecular analysis. Conclusion. Prenatal diagnosis of SMA is an essential tool in high-risk families, enabling early detection, accurate risk assessment, and informed decision-making. Implementation of genetic screening programs and counseling significantly improves clinical management and helps reduce the burden of this severe hereditary disease. Актуальность. Одной из глобальных причин смертности и инвалидности являются неврологические заболевания, большинство из которых имеют генетическую этиологию. Спинальная мышечная атрофия (СМА) — одно из наиболее распространённых аутосомно-рецессивных нервно-мышечных заболеваний, обусловленное патогенными вариантами гена SMN1 и характеризующееся прогрессирующей дегенерацией мотонейронов. Развитие молекулярной генетики и появление модифицирующих течение заболевания терапий повысили значимость ранней диагностики, включая пренатальное тестирование и скрининг носительства. Цель. Изучить роль пренатального генетического тестирования в семьях с риском СМА и оценить его значение для ранней диагностики, определения тяжести заболевания и принятия информированных репродуктивных решений. Материалы и методы. В исследование были включены беременные женщины с риском СМА. Проводился забор биоматериала (материнская кровь и фетальные образцы, полученные с помощью биопсии хориона или плацентоцентеза). ДНК выделяли и анализировали методом MLPA для оценки вариаций числа копий генов SMN1, SMN2и NAIP. Варианты, выявленные с помощью секвенирования нового поколения, подтверждались методом секвенирования по Сэнгеру. Для всех участников собирались клинические и семейные анамнезы. Обсуждение. Два клинических случая продемонстрировали значимость пренатального генетического тестирования. В первом случае оба родителя являлись носителями, однако мутации и делеции у плода выялены не были, в связи с чем было рекомендовано продолжение беременности. Во втором случае была выявлена гомозиготная делеция гена SMN1, что после консультирования привело к прерыванию беременности. Эти результаты подчеркивают ключевую роль пренатальной диагностики в выявлении поражённых плодов, принятии клинических решений и предотвращении повторных случаев заболевания. Вариабельность тяжести СМА, зависящая от числа копий SMN2, дополнительно подчёркивает необходимость комплексного молекулярного анализа. Вывод. Пренатальная диагностика СМА является важным инструментом в семьях высокого риска, обеспечивая раннее выявление, точную оценку...

30 June 2026 in Astana Medical Journal
Verified
Journal Article
Closed access
AGAidana Gabdulkayum
Aidana Gabdulkayum
SASaya Amangeldikyzy
Saya Amangeldikyzy
SKSayipzhamal Khassanova
Sayipzhamal Khassanova
AYAdil Yerezhepov
Adil Yerezhepov
UKUlan Kozhamkulov
Ulan Kozhamkulov
DYDauren Yerezhepov
Dauren Yerezhepov
Introduction. Elite athletes undergo regular high-intensity training to maintain fitness and improve performance. Training overload is necessary to achieve significant results. However, failure to balance training and recovery can lead to overtraining syndrome. To prevent this, regular monitoring of biochemical markers is required to assess the body's adaptive processes. Aim of the study. Comparative analysis of blood biochemical parameters in Olympic athletes of Kazakhstan to assess training load effects and prevent overtraining syndrome Methods. A biochemical analysis was conducted to measure levels of creatinine, creatine kinase (CK), lactate dehydrogenase (LDH), alkaline phosphatase (ALP), aspartate aminotransferase (AST), and alanine aminotransferase (ALT) in Olympic athletes. Results. Significant differences in biochemical markers were observed among sports disciplines. Creatinine (p<0.001), alkaline phosphatase (p<0.001), AST (p<0.001), CK (p=0.008), and LDH (p<0.001) levels differed significantly between groups, whereas ALT showed no significant variation (p=0.191). Post hoc analyses revealed higher creatinine levels in weightlifters and freestyle wrestlers, elevated alkaline phosphatase levels in combat sport athletes, and significant sport-specific differences in AST, CK, and LDH, reflecting variations in muscle metabolism and training-related physiological adaptation. Conclusion. These findings underscore the importance of monitoring biochemical markers in elite athletes to prevent overtraining and optimize the training process. Keywords: biochemical markers, sports medicine, creatine kinase, lactate dehydrogenase, athletes of Kazakhstan.

30 April 2026 in Astana Medical Journal
Verified
Journal Article
Closed access
AGAidana Gabdulkayum
Aidana Gabdulkayum
ZMZhanel Mirmanova
Zhanel Mirmanova
TKTomiris Kadenova
Tomiris Kadenova
MBMirgul Bayanova
Mirgul Bayanova
LNLyazzat Nazarova
Lyazzat Nazarova
DYDauren Yerezhepov
Dauren Yerezhepov
Introduction. Mitochondrial diseases (MDs) are clinically heterogeneous disorders caused by mutations across a wide spectrum of genes encoded by the nuclear or mitochondrial genome, and have complex inheritance patterns, including X-linked or autosomal inheritance for mutations in nDNA genes, and maternal inheritance for mtDNA mutations. Mitochondrial complex I (MCI) is the largest and most complicated component of the respiratory chain. The NDUFV1 gene encodes an essential core subunit of the electron-input (N) module of mitochondrial complex I within the oxidative phosphorylation (OXPHOS) system. Methods. Recruitment of the family took place at the Corporate Fund «University Medical Center» (UMC). Blood from the pregnant woman and her partner was collected into a blood collection tube. Chorionic villus sampling (CVS) was performed according to the standard operating procedure (SOP). DNA was isolated using commercially available kits. Variant verification was performed by Sanger sequencing. Sequencing data analyzed using Data Collection Software. Results. A Kazakhstani family with a history of mitochondrial complex I deficiency (MCID), nuclear type 4, autosomal recessive inheritance pattern (OMIM: 618225) was recruited on the basis of the UMC. The parents were verified by Sanger sequencing and are obligate heterozygous carriers of genetic variants in the NDUFV1 gene at the following points: mother – NM_007103.4: c.289C>T (p.Leu97Phe), father – NM_007103.4: c.357G>C (p.Glu119Asp). Prenatal testing detected both heterozygous mutations in points NM_007103.4: c.262C>T (p.Arg88Cys) and NM_007103.4 c.357G>C (p.Glu119Asp) in the fetus. It was recommended to observe by a pediatrician with no specific treatment. Also, medical and genetic counseling of the couple when planning the next pregnancy was recommended. Conclusion. NDUFV1-related MCID can lead to a broad spectrum of clinical outcomes and complications and may progress rapidly. Therefore, early recognition is essential to ensure timely diagnosis and appropriate management. Our findings highlight the importance of early prenatal genetic testing for NDUFV1-associated MCID, which can facilitate early detection and support informed decision-making during pregnancy. Key words: mitochondrial diseases, prenatal genetic testing, NDUFV1, mitochondrial complex I deficiency.